characteristics.text: SAMD00012136
characteristics.characteristic: External Id
characteristics.text: Laboratory of Kadowaki, Department of Metabolic Diseases, Graduate School of Medicine, The University of Tokyo
characteristics.characteristic: INSDC center name
characteristics.text: 2011-10-21T00:00:00Z
characteristics.characteristic: INSDC first public
characteristics.text: 2014-11-12T03:29:28Z
characteristics.characteristic: INSDC last update
characteristics.text: DRS000646
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Generic
characteristics.characteristic: NCBI submission model
characteristics.text: Generic.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: DRS000646
characteristics.characteristic: SRA accession
characteristics.text: Mus musculus
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_10090
characteristics.characteristic: organism
characteristics.text: source:3T3-L1 cells, 36h of differentiation growth_protocol:3T3-L1 cells were maintained in DMEM, supplemented with 10% FBS. For adipocyte differentiation, two days after confluence, 3T3-L1 cells were treated with dexamethasone (1 uM), IBMX (0.5 mM), and insulin (5 ug/ml) (DMI) for 48 hours, followed by treatment with insulin alone, with medium replacement every two days thereafter.
characteristics.characteristic: sample comment
characteristics.text: DRS000646
characteristics.characteristic: sample name
characteristics.text: HW_3T3L1_36h_for_CHIP
characteristics.characteristic: title